Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kristof De Vusser is active.

Publication


Featured researches published by Kristof De Vusser.


Plant Physiology | 2002

Variation in Growth Rate between Arabidopsis Ecotypes Is Correlated with Cell Division and A-Type Cyclin-Dependent Kinase Activity

Gerrit T.S. Beemster; Kristof De Vusser; Evelien De Tavernier; Kirsten De Bock; Dirk Inzé

We used a kinematic analysis to investigate the growth processes responsible for variation in primary root growth between 18 ecotypes of Arabidopsis. Root elongation rate differed 4-fold between the slowest (Landsberg erecta, 71 μm h−1) and fastest growing line (Wassilewskija [Ws]; 338 μm h−1). This difference was contributed almost equally by variations in mature cortical cell length (84 μm [Landsbergerecta] to 237 μm [Ws]) and rate of cell production (0.63 cell h−1 [NW108] to 1.83 cell h−1[Ws]). Cell production, in turn, was determined by variation in cell cycle duration (19 h [Tsu] to 48 h [NW108]) and, to a lesser extent, by differences in the number of dividing cells (32 [Weiningen] to 61 [Ws]). We found no correlation between mature cell size and endoreduplication, refuting the hypothesis that the two are linked. However, there was a strong correlation between cell production rates and the activity of the cyclin-dependent kinase (CDKA). The level of the protein could explain 32% of the variation in CDKA. Therefore, it is likely that regulators of CDKA, such as cyclins and inhibitors, are also involved. These data provide a functional link between cell cycle regulation and whole-plant growth rate as affected by genetic differences.


Applied and Environmental Microbiology | 2004

In Vivo Synthesis of Mammalian-Like, Hybrid-Type N-Glycans in Pichia pastoris

Wouter Vervecken; Vladimir Kaigorodov; Nico Callewaert; Steven Geysens; Kristof De Vusser; Roland Contreras

ABSTRACT The Pichia pastoris N-glycosylation pathway is only partially homologous to the pathway in human cells. In the Golgi apparatus, human cells synthesize complex oligosaccharides, whereas Pichia cells form mannose structures that can contain up to 40 mannose residues. This hypermannosylation of secreted glycoproteins hampers the downstream processing of heterologously expressed glycoproteins and leads to the production of protein-based therapeutic agents that are rapidly cleared from the blood because of the presence of terminal mannose residues. Here, we describe engineering of the P. pastoris N-glycosylation pathway to produce nonhyperglycosylated hybrid glycans. This was accomplished by inactivation of OCH1 and overexpression of an α-1,2-mannosidase retained in the endoplasmic reticulum and N-acetylglucosaminyltransferase I and β-1,4-galactosyltransferase retained in the Golgi apparatus. The engineered strain synthesized a nonsialylated hybrid-type N-linked oligosaccharide structure on its glycoproteins. The procedures which we developed allow glycan engineering of any P. pastoris expression strain and can yield up to 90% homogeneous protein-linked oligosaccharides.


Biotechnology Letters | 2008

Pichia surface display: display of proteins on the surface of glycoengineered Pichia pastoris strains

Pieter P. Jacobs; Stefan Ryckaert; Steven Geysens; Kristof De Vusser; Nico Callewaert; Roland Contreras

Expression of proteins on the surface of yeasts has a wide range of applications in biotechnology, such as directed evolution of proteins for increased affinity and thermal stability, screening of antibody libraries, epitope mapping, and use as whole-cell biocatalysts. However, hyperglycosylation can interfere with overall protein accessibility on the surface. Therefore, the less elaborate hyperglycosylation in wild type Pichia pastoris and the availability of glycoengineered strains make this yeast an excellent alternative for surface display of glycoproteins. Here, we report the implementation of the well-established a-agglutinin-based yeast surface display technology in P. pastoris. Four heterologous proteins were expressed on the surface of a wild type and a glycoengineered strain. Surface display levels were monitored by Western blot, immunofluorescence microscopy, and FACS analysis. The availability of glycoengineered strains makes P. pastoris an excellent alternative for surface display of glycoproteins and paves the way for new applications.


Glycobiology | 2004

Trypanosome trans-sialidase targets TrkA tyrosine kinase receptor and induces receptor internalization and activation

Alicja Woronowicz; Kristof De Vusser; Wouter Laroy; Roland Contreras; Susan O. Meakin; Gregory M. Ross; Myron R. Szewczuk


Glycobiology | 2007

Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase

Alicja Woronowicz; Schammim Ray Amith; Kristof De Vusser; Wouter Laroy; Roland Contreras; Sameh Basta; Myron R. Szewczuk


Vaccine | 2008

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection : A vaccine candidate

Germán H. Fontanella; Kristof De Vusser; Wouter Laroy; Lucas Daurelio; Ana L. Nocito; Silvia Revelli; Roland Contreras


Glycobiology | 2007

Trypanosome trans-sialidase mediates neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing PC12 cells

Alicja Woronowicz; Schammim Ray Amith; Vanessa W Davis; Preethi Jayanth; Kristof De Vusser; Wouter Laroy; Roland Contreras; Susan O. Meakin; Myron R. Szewczuk


Journal of Biotechnology | 2005

Development of a S. cerevisiae whole cell biocatalyst for in vitro sialylation of oligosaccharides.

Stefan Ryckaert; Vera Martens; Kristof De Vusser; Roland Contreras


Archive | 2007

Vaccine against trypanosoma cruzi infection

Roland Contreras; Kristof De Vusser; Silvia Revelli


Journal of Biotechnology | 2005

Development of a whole cell biocatalyst for in vitro sialylation of oligosaccharides

Stefan Ryckaert; Vera Martens; Kristof De Vusser; Roland Contreras

Collaboration


Dive into the Kristof De Vusser's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Silvia Revelli

Facultad de Ciencias Médicas

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge